SHARC International to Postpone Filing of Annual Filings Due to COVID-19 Related Delays
VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC” […]
Bhang Announces Delayed Filing of Annual Disclosure Documents
MIAMI, April 24, 2020 (GLOBE NEWSWIRE) — Bhang Inc. (“Bhang” or the “Company“) (CSE: BHNG) (OTCQX: BHNGF), a global cannabis […]
Canadian Metals Inc.: Stéphane Leblanc to File Early Warning Report
MONTREAL, April 24, 2020 (GLOBE NEWSWIRE) — Canadian Metals Inc. (“CME” or the “Company”) (CSE: CME) today reports that Mr. […]
Draganfly Concludes COVID-19 Social Distancing Test with Westport Police Department
Los Angeles, CA, April 24, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the […]
TILT Holdings – Unaware of Any Material Change
CAMBRIDGE, Mass., April 24, 2020 (GLOBE NEWSWIRE) — At the request of IIROC, TILT Holdings Inc. (“TILT” or the “Company”) […]
AgraFlora Organics complète son premier lot d’huile et de distillat de CBD
VANCOUVER, Colombie-Britannique, 24 avr. 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE : AGRA) (Frankfurt: PU31) […]
REPEAT – AgraFlora Organics Completes First Batch of CBD Oil and CBD Distillate
VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: [...]
Algernon Menerima Kelulusan Kawal Selia dan Etika bagi Kajian Manusia COVID-19 Ifenprodil Fasa 2 di Korea Selatan
VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“syarikat” atau “Algernon”) […]
Algernon erhält in Südkorea Genehmigung der Regulierungsbehörde und Ethikkommission für seine Phase-II-Humanstudie zu Ifenprodil in der Behandlung von COVID-19
VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (das „Unternehmen“ oder […]
Algernon reçoit une approbation réglementaire et éthique pour l’étude humaine de phase 2 sur l’ifenprodil dans le cadre du traitement du COVID-19 en Corée du Sud
VANCOUVER, Colombie-Britannique, 24 avr. 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE : AGN) (FRANCFORT : AGW) (OTCQB : AGNPF) (la « Société » ou […]
